Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
Open accessThe DOI matches its Crossref record; 25 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 1976, we initiated a randomized trial to determine whether lumpectomy with or without radiation therapy was as effective as total mastectomy for the treatment of invasive breast cancer. METHODS: A total of 1851 women for whom follow-up data were available and nodal status was known underwent randomly assigned treatment consisting of total mastectomy, lumpectomy alone, or lumpectomy and breast irradiation. Kaplan-Meier and cumulative-incidence estimates of the outcome were obtained. RESULTS: The cumulative incidence of recurrent tumor in the ipsilateral breast was 14.3 percent in the women who underwent lumpectomy and breast irradiation, as compared with 39.2 percent in the women who underwent lumpectomy without irradiation (P<0.001). No significant differences were observed among the three groups of women with respect to disease-free survival, distant-disease-free survival, or overall survival. The hazard ratio for death among the women who underwent lumpectomy alone, as compared with those who underwent total mastectomy, was 1.05 (95 percent confidence interval, 0.90 to 1.23; P=0.51). The hazard ratio for death among the women who underwent lumpectomy followed by breast irradiation, as compared with those who underwent total mastectomy, was 0.97 (95 percent confidence interval, 0.83 to 1.14; P=0.74). Among the lumpectomy-treated women whose surgical specimens had tumor-free margins, the hazard ratio for death among the women who underwent postoperative breast irradiation, as compared with those who did not, was 0.91 (95 percent confidence interval, 0.77 to 1.06; P=0.23). Radiation therapy was associated with a marginally significant decrease in deaths due to breast cancer. This decrease was partially offset by an increase in deaths from other causes. CONCLUSIONS: Lumpectomy followed by breast irradiation continues to be appropriate therapy for women with breast cancer, provided that the margins of resected specimens are free of tumor and an acceptable cosmetic result can be obtained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This has resulted in improved outcomes in a number of different cancers (2, 342–350).”
From Adrenocortical carcinoma (2014) · cites this paper as [344]
In the citing paper
“Breast-conserving surgery combined with radiation therapy is standard treatment for early stage breast cancer and provides equivalent survival to mastectomy [20-27].”
From Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature (2010) · cites this paper as [20]
In the citing paper
“and it can be greatly reduced by radiotherapy. 4,5”
In the citing paper
“The risk of recurrence in a conserved breast can be substantial even in node-negative disease that has been confirmed by axillary clearance”
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960 · cited 1×
“Any first recurrence «5 yr >5 and «10 yr >10 yr 161 (74) 38 (17) 20 (9) 187 (70) 55 (20) 27 (10) 133 (62) 49 (23) 32 (15) 481 (69) 142 (20) 79 (11) Local «5 yr >5 and «10 yr >10 yr 47 (78) 9 (15) 4 (7) 43 (77) 10 (18) 3 (5) 5 (29) 7 (41) 5 (29) 95 (71) 26 (20) 12 (9) Regional «5 yr >5 and «10 yr >10 yr 24 (89) 2 (7) 1…”
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121101 · Cited by 2,194
Self-citationVeronesi, U., Saccozzi, R., Del Vecchio, M., Banfi, A., Clemente, C., De Lena, M., Gallus, G., Greco, M., Luini, A., Marubini, E., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107023050102 · Cited by 1,599
Research works printed but not linked: 4
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
- Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. In: Consensus development conference on the treatment of early-stage breast cancer. Journal of the National Cancer Institute monographs. No. 11. Bethesda, Md.: National Cancer Institute, 1992:19-25. (NIH publication no. 90-3187.)
- 10.1007/BF01655182 · DOI
- Veronesi U, 1983, Int Adv Surg Oncol, 6, 141
Cited by
Breast Cancer Treatment: A Review
Waks, A. G., & Winer, E. P. (2019) · JAMA · doi:10.1001/jama.2018.19323 · Cited by 4,804
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Giuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Medical hyperspectral imaging: a review
Lu, G., & Fei, B. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.1.010901 · Cited by 2,291
“Although ∼45% of patients with breast cancer undergo primary surgical treatment with mastectomy, the rates of complete resection remain surprisingly low and re-excision rates in breast lumpectomy have been reported to be as high as 40% in some studies.(197) Residual tumors that were not apparent to the surgeon at the…”
BackgroundLong-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Mauri, D., Pavlidis, N., & Ioannidis, J. P. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji021 · Cited by 1,200
Brown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1373 · Cited by 1,081
Bartelink, H., Horiot, J.-C., Poortmans, P. M., Struikmans, H., Van den Bogaert, W., Fourquet, A., Jager, J. J., Hoogenraad, W. J., Oei, S. B., Wárlám-Rodenhuis, C. C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4991 · Cited by 1,047
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0030 · Cited by 951
National Healthcare Disparities Report
Quality (2014) · Cited by 1,011
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
Levit, L. A., Balogh, E. P., Nass, S. J., & Ganz, P. A. (2014) · Cited by 1,040
A review of clinical photoacoustic imaging: Current and future trends
Attia, A. B. E., Balasundaram, G., Moothanchery, M., Dinish, U. S., Bi, R., Ntziachristos, V., & Olivo, M. (2019) · Photoacoustics · doi:10.1016/j.pacs.2019.100144 · Cited by 878
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892
Burstein, H. J., Curigliano, G., Thürlimann, B., Weber, W. P., Poortmans, P., Regan, M. M., Senn, H. J., Winer, E. P., Gnant, M., Aebi, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.06.023 · Cited by 821
Smith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Julian, T. B., Marks, L. B., Todor, D. A., Vicini, F. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.031 · Cited by 872
Veronesi, U., Orecchia, R., Maisonneuve, P., Viale, G., Rotmensz, N., Sangalli, C., Luini, A., Veronesi, P., Galimberti, V., Zurrida, S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70497-2 · Cited by 767
Pignol, J.-P., Olivotto, I., Rakovitch, E., Gardner, S., Sixel, K., Beckham, W., Vu, T. T. T., Truong, P., Ackerman, I., & Paszat, L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2488 · Cited by 769
Fat Grafting to the Breast Revisited: Safety and Efficacy
Coleman, S. R., & Saboeiro, A. P. (2007) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000252001.59162.c9 · Cited by 724
Delivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70141-3 · Cited by 718
Bijker, N., Meijnen, P., Peterse, J. L., Bogaerts, J., Van Hoorebeeck, I., Julien, J.-P., Gennaro, M., Rouanet, P., Avril, A., Fentiman, I. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1366 · Cited by 663
Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
Polgár, C., Limbergen, E. V., Pötter, R., Kovács, G., Polo, A., Lyczek, J., Hildebrandt, G., Niehoff, P., Guinot, J. L., Guedea, F., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.014 · Cited by 633
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
Narod, S. A., Iqbal, J., Giannakeas, V., Sopik, V., & Sun, P. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2510 · Cited by 613
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3481-4 · Cited by 612
“Multiple randomized phase III trials with mature followup have conclusively demonstrated that survival after breast-conserving therapy (BCT), defined as surgical excision of the primary tumor and a margin of surrounding normal tissue followed by whole-breast radiation therapy (WBRT), is equivalent to mastectomy for th…”
Overview of Breast Cancer Therapy
Moo, T.-A., Sanford, R., Dang, C., & Morrow, M. (2018) · PET Clinics · doi:10.1016/j.cpet.2018.02.006 · Cited by 551
Poggi, M. M., Danforth, D. N., Sciuto, L. C., Smith, S. L., Steinberg, S. M., Liewehr, D. J., Menard, C., Lippman, M. E., Lichter, A. S., & Altemus, R. M. (2003) · Cancer · doi:10.1002/cncr.11580 · Cited by 569
“results support the findings of two recently published randomized trials, which arrived at similar conclusions.(5,6) In those studies, there was no statistically significant difference in overall survival, disease-free survival, or distant disease-free survival.”
BackgroundResultLitière, S., Werutsky, G., Fentiman, I. S., Rutgers, E., Christiaens, M.-R., Van Limbergen, E., Baaijens, M. H., Bogaerts, J., & Bartelink, H. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70042-6 · Cited by 551
Breast Cancer Treatments: Updates and New Challenges
Burguin, A., Diorio, C., & Durocher, F. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080808 · Cited by 488
“Studies show that total mastectomy and lumpectomy plus irradiation are equivalent regarding relapse-free and overall survival (OS) [19].”
BackgroundHoussami, N., Macaskill, P., Luke Marinovich, M., & Morrow, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3480-5 · Cited by 532
“Adoption of wider relative to narrower margin widths to declare negative margins is unlikely to have a substantial additional benefit for long-term local control in BCT.”
InfluentialUnderstanding of regional variation in the use of surgery
Birkmeyer, J. D., Reames, B. N., McCulloch, P., Carr, A. J., Campbell, W. B., & Wennberg, J. E. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61215-5 · Cited by 523
Pathogenesis, prevention, diagnosis and treatment of breast cancer
Shah, R. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.283 · Cited by 329
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Lucci, A., Hall, C. S., Lodhi, A. K., Bhattacharyya, A., Anderson, A. E., Xiao, L., Bedrosian, I., Kuerer, H. M., & Krishnamurthy, S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70209-7 · Cited by 507
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.11.012 · Cited by 495
Use of Statistics to Assess the Global Burden of Breast Cancer
Parkin, D. M., & Fernandez, L. M. G. (2006) · The Breast Journal · doi:10.1111/j.1075-122x.2006.00205.x · Cited by 497
Molecular Subtypes and Local-Regional Control of Breast Cancer
Fragomeni, S. M., Sciallis, A., & Jeruss, J. S. (2018) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2017.08.005 · Cited by 450
Vicini, F. A., Cecchini, R. S., White, J. R., Arthur, D. W., Julian, T. B., Rabinovitch, R. A., Kuske, R. R., Ganz, P. A., Parda, D. S., Scheier, M. F., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32514-0 · Cited by 480
Self-citationDrug Combinations in Breast Cancer Therapy
Fisusi, F. A., & Akala, E. O. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190122111224 · Cited by 449
“BCS compares favorably to total mastectomy regarding overall survival and local recurrence rates, while allowing patients to keep their breasts without excessive disfiguration [25, 26].”
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.3935 · Cited by 451
Livi, L., Meattini, I., Marrazzo, L., Simontacchi, G., Pallotta, S., Saieva, C., Paiar, F., Scotti, V., De Luca Cardillo, C., Bastiani, P., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.013 · Cited by 460
“The standard treatment for early breast cancer (BC) patients is based on breast conservative surgery (BCS) followed by whole-breast irradiation (WBI) [1,2].”
BackgroundWapnir, I. L., Anderson, S. J., Mamounas, E. P., Geyer, C. E., Jeong, J.-H., Tan-Chiu, E., Fisher, B., & Wolmark, N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3273 · Cited by 466
Self-citationAnderson, S. J., Wapnir, I., Dignam, J. J., Fisher, B., Mamounas, E. P., Jeong, J.-H., Geyer, C. E., Wickerham, D. L., Costantino, J. P., & Wolmark, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8424 · Cited by 458
Self-citationCarlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0012 · Cited by 450
Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
Arvold, N. D., Taghian, A. G., Niemierko, A., Abi Raad, R. F., Sreedhara, M., Nguyen, P. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1105 · Cited by 452
Boughey, J. C., McCall, L. M., Ballman, K. V., Mittendorf, E. A., Ahrendt, G. M., Wilke, L. G., Taback, B., Leitch, A. M., Flippo-Morton, T., & Hunt, K. K. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000924 · Cited by 440
The incidence and functional consequences of RT-associated cardiac perfusion defects
Marks, L. B., Yu, X., Prosnitz, R. G., Zhou, S.-M., Hardenbergh, P. H., Blazing, M., Hollis, D., Lind, P., Tisch, A., Wong, T. Z., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.029 · Cited by 436
van Maaren, M. C., de Munck, L., de Bock, G. H., Jobsen, J. J., van Dalen, T., Linn, S. C., Poortmans, P., Strobbe, L. J. A., & Siesling, S. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30067-5 · Cited by 430
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Clusan, L., Ferrière, F., Flouriot, G., & Pakdel, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076834 · Cited by 382
Whelan, T. J., Julian, J. A., Berrang, T. S., Kim, D.-H., Germain, I., Nichol, A. M., Akra, M., Lavertu, S., Germain, F., Fyles, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32515-2 · Cited by 427
Wang, S.-L., Fang, H., Song, Y.-W., Wang, W.-H., Hu, C., Liu, Y.-P., Jin, J., Liu, X.-F., Yu, Z.-H., Ren, H., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30813-1 · Cited by 396
Houssami, N., Macaskill, P., Marinovich, M. L., Dixon, J. M., Irwig, L., Brennan, M. E., & Solin, L. J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.043 · Cited by 406
Progress in adjuvant chemotherapy for breast cancer: an overview
Anampa, J., Makower, D., & Sparano, J. A. (2015) · BMC Medicine · doi:10.1186/s12916-015-0439-8 · Cited by 373
“Randomized trials subsequently showed no benefit from radical mastectomy compared with less aggressive surgical procedures, and demonstrated that distant recurrence remained a major clinical problem irrespective of the primary surgical therapy [10, 11].”
BackgroundXing, Y., Foy, M., Cox, D. D., Kuerer, H. M., Hunt, K. K., & Cormier, J. N. (2006) · Journal of British Surgery · doi:10.1002/bjs.5209 · Cited by 402
Contemporary radiotherapy: present and future
Chandra, R. A., Keane, F. K., Voncken, F. E. M., & Thomas, C. R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00233-6 · Cited by 380
Harris, E. E. R., Correa, C., Hwang, W.-T., Liao, J., Litt, H. I., Ferrari, V. A., & Solin, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1037 · Cited by 393
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Agarwal, S., Pappas, L., Neumayer, L., Kokeny, K., & Agarwal, J. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.3049 · Cited by 391
Effects of Age on the Detection and Management of Breast Cancer
McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M. (2015) · Cancers · doi:10.3390/cancers7020815 · Cited by 374
“The most common surgical intervention for breast cancer treatment is wide local excision (WLE), which has similar outcomes to mastectomy while reducing surgical complications [121,122].”
BackgroundMcCormick, B., Winter, K., Hudis, C., Kuerer, H. M., Rakovitch, E., Smith, B. L., Sneige, N., Moughan, J., Shah, A., Germain, I., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9029 · Cited by 392
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Lowery, A. J., Kell, M. R., Glynn, R. W., Kerin, M. J., & Sweeney, K. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1891-6 · Cited by 389
A Meta-Analysis Comparing Breast Conservation Therapy Alone to the Oncoplastic Technique
Losken, A., Dugal, C. S., Styblo, T. M., & Carlson, G. W. (2014) · Annals of Plastic Surgery · doi:10.1097/sap.0b013e3182605598 · Cited by 373
“B reast conservation therapy (BCT) has comparable survival and acceptable recurrence rates for women with breast cancer when compared to total mastectomy.(1,2) The second major goal with BCT is to preserve breast shape and symmetry, which is unfortunately not always obtained.”
BackgroundA Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer
Chagpar, A. B., Killelea, B. K., Tsangaris, T. N., Butler, M., Stavris, K., Li, F., Yao, X., Bossuyt, V., Harigopal, M., Lannin, D. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504473 · Cited by 367
Pleijhuis, R. G., Graafland, M., de Vries, J., Bart, J., de Jong, J. S., & van Dam, G. M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0609-z · Cited by 361
Vinh-Hung, V., & Verschraegen, C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh013 · Cited by 365
“In the NSABP B-06 trial, which was a threearm trial of lumpectomy versus lumpectomy plus radiotherapy versus mastectomy, Fisher et al. ( 3 ) reported rates of ipsilateral breast tumor recurrence when comparing radiotherapy with no radiotherapy but used chest wall recurrences when comparing lumpectomy with mastectomy.”
BackgroundMethodInfluentialPolgár, C., Fodor, J., Major, T., Sulyok, Z., & Kásler, M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.008 · Cited by 358
“Over the last three decades, breast-conserving therapy (BCT) including surgical removal of the primary tumor and whole breast irradiation (WBI) consisting of 5 weeks of external beam radiotherapy (EBRT) with or without an additional 1–2 weeks of boost irradiation to the tumor bed, became the standard of care for the t…”
BackgroundAnderson, B. O., Shyyan, R., Eniu, A., Smith, R. A., Yip, C.-H., Bese, N. S., Chow, L. W. C., Masood, S., Ramsey, S. D., & Carlson, R. W. (2006) · The Breast Journal · doi:10.1111/j.1075-122x.2006.00199.x · Cited by 359
Jeevan, R., Cromwell, D. A., Trivella, M., Lawrence, G., Kearins, O., Pereira, J., Sheppard, C., Caddy, C. M., & van der Meulen, J. H. P. (2012) · BMJ · doi:10.1136/bmj.e4505 · Cited by 347
Oncoplastic approaches to partial mastectomy: an overview of volume-displacement techniques
Anderson, B. O., Masetti, R., & Silverstein, M. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01765-1 · Cited by 353
Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination
Le, C. P., Nowell, C. J., Kim-Fuchs, C., Botteri, E., Hiller, J. G., Ismail, H., Pimentel, M. A., Chai, M. G., Karnezis, T., Rotmensz, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10634 · Cited by 354
Bilimoria, K. Y., Bentrem, D. J., Hansen, N. M., Bethke, K. P., Rademaker, A. W., Ko, C. Y., Winchester, D. P., & Winchester, D. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.5750 · Cited by 350
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
Mahvi, D. A., Liu, R., Grinstaff, M. W., Colson, Y. L., & Raut, C. P. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21498 · Cited by 338
Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases
Rouhani, P., Fletcher, C. D. M., Devesa, S. S., & Toro, J. R. (2008) · Cancer · doi:10.1002/cncr.23571 · Cited by 342
Solin, L. J., Orel, S. G., Hwang, W.-T., Harris, E. E., & Schnall, M. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.5448 · Cited by 346
Abdulkarim, B. S., Cuartero, J., Hanson, J., Deschênes, J., Lesniak, D., & Sabri, S. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4714 · Cited by 345
Polgár, C., Fodor, J., Major, T., Németh, G., Lövey, K., Orosz, Z., Sulyok, Z., Takácsi-Nagy, Z., & Kásler, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.022 · Cited by 346
Pierce, L. J., Levin, A. M., Rebbeck, T. R., Ben-David, M. A., Friedman, E., Solin, L. J., Harris, E. E., Gaffney, D. K., Haffty, B. G., Dawson, L. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7888 · Cited by 340
McGuire, K. P., Santillan, A. A., Kaur, P., Meade, T., Parbhoo, J., Mathias, M., Shamehdi, C., Davis, M., Ramos, D., & Cox, C. E. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0635-x · Cited by 326
Two Hundred Years of Cancer Research
DeVita, V. T., & Rosenberg, S. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204479 · Cited by 318
Local Therapy and Survival in Breast Cancer
Punglia, R. S., Morrow, M., Winer, E. P., & Harris, J. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065241 · Cited by 317
Cardoso, F., Loibl, S., Pagani, O., Graziottin, A., Panizza, P., Martincich, L., Gentilini, O., Peccatori, F., Fourquet, A., Delaloge, S., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.004 · Cited by 304
Yip, C.-H., Smith, R. A., Anderson, B. O., Miller, A. B., Thomas, D. B., Ang, E.-S., Caffarella, R. S., Corbex, M., Kreps, G. L., McTiernan, A., et al. (2008) · Cancer · doi:10.1002/cncr.23842 · Cited by 301
Patt, D. A., & Giordano, S. H. (2007) · Breast Diseases: A Year Book Quarterly · doi:10.1016/s1043-321x(07)80352-3 · Cited by 305
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0037 · Cited by 304
Blichert-Toft, M., Nielsen, M., Düring, M., Møller, S., Rank, F., Overgaard, M., & Mouridsen, H. T. (2008) · Acta Oncologica · doi:10.1080/02841860801971439 · Cited by 300
Owusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F., Prout, M., Yood, M. U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1022 · Cited by 304
Dual equipoise shared decision making: definitions for decision and behaviour support interventions
Elwyn, G., Frosch, D., & Rollnick, S. (2009) · Implementation Science · doi:10.1186/1748-5908-4-75 · Cited by 289
“Research indicates that the outcomes of mastectomy and breast conservation surgery are more or less comparable in terms of mortality, but that important differences exist for patients' quality of life [ 26 ,27].”
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
Whitley, M. J., Cardona, D. M., Lazarides, A. L., Spasojevic, I., Ferrer, J. M., Cahill, J., Lee, C.-L., Snuderl, M., Blazer, D. G., Hwang, E. S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0293 · Cited by 296
Didier, F., Radice, D., Gandini, S., Bedolis, R., Rotmensz, N., Maldifassi, A., Santillo, B., Luini, A., Galimberti, V., Scaffidi, E., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0238-4 · Cited by 291
“Nowadays breast cancer surgery has become less and less mutilating and it is now accepted that early-breast cancer patients treated either by mastectomy or by breast-conserving procedures have comparable survival rates [1, 2].”
BackgroundNewman, E. A., Guest, A. B., Helvie, M. A., Roubidoux, M. A., Chang, A. E., Kleer, C. G., Diehl, K. M., Cimmino, V. M., Pierce, L., Hayes, D., et al. (2006) · Cancer · doi:10.1002/cncr.22266 · Cited by 290
The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation
Shah, C., Vicini, F., Shaitelman, S. F., Hepel, J., Keisch, M., Arthur, D., Khan, A. J., Kuske, R., Patel, R., & Wazer, D. E. (2018) · Brachytherapy · doi:10.1016/j.brachy.2017.09.004 · Cited by 291
Waljee, J. F., Hu, E. S., Ubel, P. A., Smith, D. M., Newman, L. A., & Alderman, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1375 · Cited by 288
Tubiana, M. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.12.016 · Cited by 280
Limited-Field Radiation Therapy in the Management of Early-Stage Breast Cancer
Vicini, F. A., Kestin, L., Chen, P., Benitez, P., Goldstein, N. S., & Martinez, A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg023 · Cited by 280
Progress in adjuvant systemic therapy for breast cancer
Pondé, N. F., Zardavas, D., & Piccart, M. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0089-9 · Cited by 281
Brackstone, M., Baldassarre, F. G., Perera, F. E., Cil, T., Chavez Mac Gregor, M., Dayes, I. S., Engel, J., Horton, J. K., King, T. A., Kornecki, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00934 · Cited by 271
Abrams, R. A., Winter, K. A., Regine, W. F., Safran, H., Hoffman, J. P., Lustig, R., Konski, A. A., Benson, A. B., Macdonald, J. S., Rich, T. A., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.039 · Cited by 278
“However in both breast cancer and prostate cancer regional involvement often manifests first as systemic rather than regional failure (39,40).”
BackgroundRadiotherapy and breast reconstruction: a meta-analysis
Barry, M., & Kell, M. R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1401-x · Cited by 274
Benson, J. R., Jatoi, I., Keisch, M., Esteva, F. J., Makris, A., & Jordan, V. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60316-0 · Cited by 261
Long-term oncological results of breast conservative treatment with oncoplastic surgery
Rietjens, M., Urban, C. A., Rey, P. C., Mazzarol, G., Maisonneuve, P., Garusi, C., Intra, M., Yamaguchi, S., Kaur, N., De Lorenzi, F., et al. (2007) · The Breast · doi:10.1016/j.breast.2007.01.008 · Cited by 268
Metadata
- Authors
- Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N.
- Affiliations
- University of Pittsburgh (US)
- NSABP Foundation (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-10-17
- Volume
- 347
- Issue
- 16
- Pages
- 1233-1241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2067420088
- Semantic Scholar
- 4468d9b99c6cf981372c46aebe6895549bc34b70
- Cited by
- 6,249
- References
- 28
- Citations by year
- 2026: 190 · 2025: 212 · 2024: 241 · 2023: 306 · 2022: 302 · 2021: 328 · 2020: 320 · 2019: 290 · 2018: 284 · 2017: 289 · 2016: 334 · 2015: 340 · 2014: 318 · 2013: 331 · 2012: 321
- FWCI
- 52.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (U10-CA37377, U10CA069651, U10CA037377, U10CA069974, U10 CA 69651, U10-CA-69974)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- invasive breast cancer, total mastectomy, breast-conserving surgery, breast cancer radiotherapy, breast-conserving therapy, ipsilateral breast tumor recurrence, disease-free survival, overall survival, long-term outcomes
- MeSH terms
- Breast Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Mastectomy, Radical, Mastectomy, Segmental, Incidence, Survival Analysis, Randomized Controlled Trials as Topic, Neoplasms, Second Primary, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.